Despite cannabis’ history in folk pharmacopoeias, clinical studies of its medicinal impact remain limited in many areas. Based on some promising early results, researchers are now calling for a closer look at its applications for certain mental health conditions
Meet the Cannabis Beauty Line That’s Turning Your Daily Slick of Lip Balm Into a Wellness Moment Written by Molly Creeden Photographed by Hanna Tveite
“There are people who may be thinking: I’m not really into cannabis—I’ve never done it. I was that person,” says Claudia Mata, a former New York City–based fashion editor. “Ten years ago, I wouldn’t have said, ‘Oh, yeah, I’m starting a cannabis company.’ ”
Medicinal cannabis ‘red-tape’ pushing doctors and patients back to illegal products Written by David Lipson
A mountain of red tape for legal medicinal cannabis is forcing the families of seriously ill patients back into the black market, according to doctors and advocates.
Scientific Community Pushes Back Against V.A.’s Latest “Worthless” Medical Marijuana Studies Written by Mike Adams
According to the scientific community, recent studies funded by the department of Veteran Affairs that claim cannabis is inefficient at treating PTSD are just “retreading the same materials.”
Cannabis-friendly trauma patients are less likely to die in-hospital than age-matched controls, a new study published in the Journal of Trauma and Acute Care Surgery found.
Marijuana use may be a cause of high blood pressure, a new study reports. Researchers studied 332 deaths among 1,213 people
Despite the nonsensical naysaying by Reefer Madness prohibitionists, medical cannabis now enjoys mainstream acceptance across the United States, (and support is increasing around the world).
Researchers at Oxford University are to undertake a £10 million study on the medical benefits of marijuana in treating pain, cancer and inflammatory diseases.
How Cannabis Prevents Insulin Resistance in Patients Co-infected With HIV and Hepatitis C Written by Ben Adams
Drug resistance is a real threat for HIV+ patients. A nagging worry that doesn’t go away. Patients frequently develop resistance to medications because of the high mutation rate of HIV.